- Home
- ODD vs ENOV Comparison
ODD vs ENOV Comparison
Compare ODD & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODD
- ENOV
- Stock Information
- Founded
- ODD 2018
- ENOV 1995
- Country
- ODD Israel
- ENOV United States
- Employees
- ODD N/A
- ENOV N/A
- Industry
- ODD
- ENOV Fluid Controls
- Sector
- ODD
- ENOV Industrials
- Exchange
- ODD Nasdaq
- ENOV Nasdaq
- Market Cap
- ODD 2.3B
- ENOV 2.1B
- IPO Year
- ODD 2023
- ENOV 2008
- Fundamental
- Price
- ODD $67.74
- ENOV $33.10
- Analyst Decision
- ODD Buy
- ENOV Buy
- Analyst Count
- ODD 8
- ENOV 4
- Target Price
- ODD $54.63
- ENOV $58.50
- AVG Volume (30 Days)
- ODD 1.1M
- ENOV 986.0K
- Earning Date
- ODD 04-29-2025
- ENOV 05-08-2025
- Dividend Yield
- ODD N/A
- ENOV N/A
- EPS Growth
- ODD 45.36
- ENOV N/A
- EPS
- ODD 1.74
- ENOV N/A
- Revenue
- ODD $703,488,000.00
- ENOV $2,150,191,000.00
- Revenue This Year
- ODD $22.39
- ENOV $7.13
- Revenue Next Year
- ODD $20.09
- ENOV $6.33
- P/E Ratio
- ODD $38.12
- ENOV N/A
- Revenue Growth
- ODD 26.83
- ENOV 18.32
- 52 Week Low
- ODD $32.71
- ENOV $29.32
- 52 Week High
- ODD $69.96
- ENOV $53.84
- Technical
- Relative Strength Index (RSI)
- ODD 82.59
- ENOV 41.77
- Support Level
- ODD $39.55
- ENOV $33.48
- Resistance Level
- ODD $43.14
- ENOV $35.62
- Average True Range (ATR)
- ODD 3.74
- ENOV 1.32
- MACD
- ODD 2.42
- ENOV 0.20
- Stochastic Oscillator
- ODD 92.70
- ENOV 49.20
About ODD ODDITY Tech Ltd.
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage.
About ENOV Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.